RAPISAFE Trademark

Trademark Overview


On Tuesday, December 14, 2021, a trademark application was filed for RAPISAFE with the United States Patent and Trademark Office. The USPTO has given the RAPISAFE trademark a serial number of 79332919. The federal status of this trademark filing is REGISTERED as of Tuesday, July 18, 2023. This trademark is owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.. The RAPISAFE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the functional analysis of blood coagulation and fibrinolysis; Pharmaceutical preparations for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Chemico-pharmaceutical preparations for pharmaceutical purposes, namely, chemico-pharmaceutical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; Chemico-pharmaceutical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Medicated serums used for the functional analysis of blood coagulation and fibrinolysis; Medicated serums used for the quantitative and qualitative detection of analytes in human serum, plasma and body fluids; Medicines for serum therapy, namely, medicines for serum therapy for functional analysis of blood coagulation and fibrinolysis; Medicines for serum therapy for ...
rapisafe

General Information


Serial Number79332919
Word MarkRAPISAFE
Filing DateTuesday, December 14, 2021
Status700 - REGISTERED
Status DateTuesday, July 18, 2023
Registration Number7109718
Registration DateTuesday, July 18, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the functional analysis of blood coagulation and fibrinolysis; Pharmaceutical preparations for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Chemico-pharmaceutical preparations for pharmaceutical purposes, namely, chemico-pharmaceutical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; Chemico-pharmaceutical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Medicated serums used for the functional analysis of blood coagulation and fibrinolysis; Medicated serums used for the quantitative and qualitative detection of analytes in human serum, plasma and body fluids; Medicines for serum therapy, namely, medicines for serum therapy for functional analysis of blood coagulation and fibrinolysis; Medicines for serum therapy for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Biological preparations for medical purposes, namely, biological preparations for medical purposes for the functional analysis of blood coagulation and fibrinolysis; Biological preparations for medical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Chemical preparations for pharmaceutical purposes, namely, chemical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; Chemical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; chemical preparations for medical purposes, namely, chemical preparations for medical purposes for the functional analysis of blood coagulation and fibrinolysis; chemical preparations for medical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; enzymes for medical purposes; enzyme preparations for medical purposes; Preparations for pharmaceutical purposes, namely, preparations for pharmaceutical purposes made of trace elements that are found in the human body for the functional analysis of blood coagulation and fibrinolysis; Preparations for pharmaceutical purposes made of trace elements that are found in the human body for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; amino acids for medical purposes; preparations of microorganisms for medical or veterinary use; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; veterinary preparations for treatment of intestinal bacteria; medicines for veterinary purposes for treatment of intestinal bacteria; biological preparations for veterinary purposes for treatment of intestinal bacteria; chemical preparations for veterinary purposes for treatment of intestinal bacteria; enzymes for veterinary purposes; enzyme preparations for veterinary purposes; diagnostic preparations for veterinary purposes; reagent paper for veterinary purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameSHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameSHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, December 18, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, October 18, 2023GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, October 18, 2023GENERIC MADRID TRANSACTION CREATED
Wednesday, October 18, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, July 31, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, July 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 18, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, July 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, May 2, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023PUBLISHED FOR OPPOSITION
Monday, May 1, 2023NOTIFICATION PROCESSED BY IB
Wednesday, April 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 12, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 4, 2023REFUSAL PROCESSED BY IB
Friday, December 9, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 8, 2022REFUSAL PROCESSED BY MPU
Wednesday, September 28, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 27, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 21, 2022ASSIGNED TO EXAMINER
Tuesday, February 15, 2022APPLICATION FILING RECEIPT MAILED
Friday, February 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 10, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB